Skip to main content

Pharmacy Benefit Management Market Size To Surpass USD 809.79 billion by 2030, exhibiting A CAGR Of 6.0%

Written by Customer Service on . Posted in Mergers And Acquisitions.

As per the report by Fortune Business Insights, the global Pharmacy Benefit Management Market size is projected to reach USD 809.79 billion by 2030, at a CAGR of 6.0% during the forecast period

Pharmacy Benefit Management (PBM) Market

Pharmacy Benefit Management (PBM) Market (2023-2030)
Pharmacy Benefit Management (PBM) Market (2023-2030)

Pune, India, Oct. 06, 2023 (GLOBE NEWSWIRE) — The pharmacy benefit management market size was valued at USD 513.98 billion in 2022 and it is projected to grow from USD 540.32 billion in 2023 to USD 809.79 billion by 2030, exhibiting a CAGR of 6.0% during forecast 2023-2030. The growth of the pharmacy benefit management (PBM) market is being driven by the increasing prevalence of chronic diseases, the rising cost of prescription drugs, and the growing demand for speciality drugs.

Pharmacy Benefit Management (PBM) services help to negotiate with several drug producers and retail pharmacies to manage worldwide branded and generic drug spending. The rising demand for PBM services, drug price inflation, and the increasing incidences of chronic diseases are anticipated to propel the market growth of pharmacy benefit management during the forecast period.


Key Industry Development

July 2023 –  CVS Caremark announced a partnership with the discount drug service provider GoodRx to reduce out-of-pocket prescription costs for millions of people.


Request A Research Sample PDF: https://www.fortunebusinessinsights.com/enquiry/sample/pharmacy-benefit-management-pbm-market-103496


Key Takeaways:

  • The growth of the PBM market is being driven by the increasing prevalence of chronic diseases, the rising cost of prescription drugs, and the growing demand for speciality drugs.
  • The PBM market is segmented by payer type, service type, and region.
  • The key players in the PBM market are CVS Health, Express Scripts, and OptumRx.
  • These companies are investing in technology, data analytics, and new services to maintain their competitive edge in the market.
  • The PBM market is facing some challenges, such as the increasing complexity of the drug supply chain, the rise of generic drugs, and the growing demand for transparency and accountability.


Discover the Leading Players Featured in the Report:

Major players in the pharmacy benefit management market are CVS Health (U.S.), Cigna (U.S.), OptumRx, Inc. (U.S.), Anthem, Inc. (U.S.), Centene Corporation (U.S.), Abarca Health LLC. (U.S.), Medimpact (U.S.).


Report Scope:

Report CoverageDetails
Forecast Period2023 to 2030
Forecast Period 2023 to 2030 CAGR6.0%
2030 Value ProjectionUSD 809.79 Billion
Base Year2022
Market Size in 2023USD 540.32 Billion
Historical Data for2019 to 2021
No. of Pages98


To know how our report can help streamline your business, Speak To Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/pharmacy-benefit-management-pbm-market-103496


Drivers & Restraints

Rising Chronic Diseases Prevalence to Boost Market Growth

The rising prevalence of chronic diseases worldwide increases the demand for various treatment options, boosting market growth during the forecast period. The increasing focus of large pharmaceutical companies on developing costly and branded medications to treat chronic diseases is driving the pharmacy benefit management market growth during the forecast period.

The increasing issues related to various transparencies with PBM business practices may hamper market growth. 


Report Scope & Segmentation:

By Service

  • Specialty Pharmacy Services
  • Benefit Plan Design & Administration
  • Pharmacy Claims Processing
  • Formulary Management
  • Others

By Service Provider

  • Insurance Companies
  • Retail Pharmacies
  • Standalone PBMs

By Country/Region

  • U.S.
  • Canada
  • Rest of World


Quick Buy – Pharmacy Benefits Management Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/103496


Increasing Prevalence of Chronic Diseases to Boost Specialty Pharmacy Services Segment Growth

By service, the market is segmented into specialty pharmacy service, benefit plan design & administration, pharmacy claims processing, formulary management, and others. The specialty pharmacy services segment held the largest pharmacy benefit management market share in 2022 owing to the increasing prevalence of rare chronic diseases, which propelled the demand for several treatment options worldwide.

Insurance Companies Segment Dominates due to their Rising Acquisitions and Mergers with PBMs

Based on service provider, the market is divided into insurance companies, retail pharmacies, ad standalone PBMs. The insurance companies segment is expected to dominate the market during the forecast period owing to the rising number of mergers and acquisitions between PBM service providers and insurance companies worldwide.

Geographically, the market is studied across the U.S., Canada, and the Rest of the World.


Regional Insights

Increasing Number of Pharmacy Benefit Managers to Drive Market Growth in the U.S.

The PBM market in the U.S. was valued at USD 498.47 billion in 2022. The region is estimated to dominate the market during the forecast period owing to the rising number of pharmacy benefit managers.

Canada is estimated to grow at the highest CAGR during the forecast period. The growth is attributed to the growing prescription filing and rising demand for pharmacy benefit management services in Canada.


Ask For Customization:  https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/pharmacy-benefit-management-pbm-market-103496


Competitive Landscape

Rising Key Players’ Focus on Launching New Services and Solutions to Propel Market Growth

The market consists of major players, including Medimpact and Anthem, Inc. The increasing focus of these companies on launching new features and solutions to boost their customer reach and expand portfolios is aiding the pharmacy benefit management market growth.


FAQ’s

How Big Is The Pharmacy Benefit Management Market?

Pharmacy Benefit Management Market size Is USD 540.32 billion in 2023.

How Fast is the Pharmacy Benefit Management Market Growing?

The Pharmacy Benefit Management Market will exhibit a CAGR of 6.0% during the forecast period, 2023-2030


Related Reports:

Diabetes Treatment Devices Market Share, Trends and Forecast To 2030

Surgical Robots Market Size, Share, Trends, Growth | Global Forecast Report 2030

Next-generation Sequencing Market Size, Share| Global Forecast Report 2030

Medical Carts Market Trends, Growth | Global Forecast Report 2030


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. 

Contact Us:

Fortune Business Insights Pvt. Ltd.
9th Floor, Icon Tower,
Baner – Mahalunge Road, Pune-411045,
Maharashtra, India.

Phone:

US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.